Literature DB >> 2587422

Cholecystokinin receptors mediate enhanced memory retention produced by feeding and gastrointestinal peptides.

J F Flood1, J E Morley.   

Abstract

Ingestion of food in mice following training on T-maze footshock avoidance enhanced memory retention when tested 7 days later. This eating-induced improvement of retention was blocked by a specific cholecystokinin antagonist, L-364,718. The cholecystokinin antagonist prevented enhancement of memory retention resulting from posttraining administration of the gastrointestinal hormones, cholecystokinin, bombesin or gastrin releasing peptide. L-364,718 neither impaired or improved retention when given alone. Specificity of the effect of L-364,718 was demonstrated by the failure of L-364,718 to block improved memory retention resulting from administration of arecoline and D-amphetamine. The studies provide evidence that activation of cholecystokinin receptors plays a physiological role in the mediation of meal-induced enhancement of memory retention.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2587422     DOI: 10.1016/0196-9781(89)90118-6

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  3 in total

1.  Electrophysiological responses of nucleus tractus solitarius neurons to CCK and gastric distension in newborn lambs.

Authors:  Rosalinda Guevara-Guzmán; Frederic Lévy; Andre Jean; Raymond Nowak
Journal:  Cell Mol Neurobiol       Date:  2005-03       Impact factor: 5.046

2.  The delivery rate of dietary carbohydrates affects cognitive performance in both rats and humans.

Authors:  David Benton; Marie-Pierre Ruffin; Taous Lassel; Samantha Nabb; Michaël Messaoudi; Sophie Vinoy; Didier Desor; Vincent Lang
Journal:  Psychopharmacology (Berl)       Date:  2002-12-12       Impact factor: 4.530

3.  CCK-A and CCK-B selective receptor agonists and antagonists modulate olfactory recognition in male rats.

Authors:  M Lemaire; G A Böhme; O Piot; B P Roques; J C Blanchard
Journal:  Psychopharmacology (Berl)       Date:  1994-08       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.